IL179072A0 - Novel use of peptide compounds for treating dyskinesia - Google Patents

Novel use of peptide compounds for treating dyskinesia

Info

Publication number
IL179072A0
IL179072A0 IL179072A IL17907206A IL179072A0 IL 179072 A0 IL179072 A0 IL 179072A0 IL 179072 A IL179072 A IL 179072A IL 17907206 A IL17907206 A IL 17907206A IL 179072 A0 IL179072 A0 IL 179072A0
Authority
IL
Israel
Prior art keywords
peptide compounds
novel use
treating dyskinesia
dyskinesia
treating
Prior art date
Application number
IL179072A
Original Assignee
Sanol Arznei Schwarz Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04011833A external-priority patent/EP1604654A1/en
Application filed by Sanol Arznei Schwarz Gmbh filed Critical Sanol Arznei Schwarz Gmbh
Publication of IL179072A0 publication Critical patent/IL179072A0/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/165Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL179072A 2004-05-18 2006-11-06 Novel use of peptide compounds for treating dyskinesia IL179072A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57193204P 2004-05-18 2004-05-18
EP04011833A EP1604654A1 (en) 2004-05-18 2004-05-18 Novel use of peptide compounds for treating dyskinesia
PCT/EP2005/005355 WO2005110390A1 (en) 2004-05-18 2005-05-17 Novel use of peptide compounds for treating dyskinesia

Publications (1)

Publication Number Publication Date
IL179072A0 true IL179072A0 (en) 2008-03-20

Family

ID=34969829

Family Applications (1)

Application Number Title Priority Date Filing Date
IL179072A IL179072A0 (en) 2004-05-18 2006-11-06 Novel use of peptide compounds for treating dyskinesia

Country Status (4)

Country Link
KR (1) KR20070010168A (en)
IL (1) IL179072A0 (en)
NO (1) NO20065829L (en)
TW (1) TW200701983A (en)

Also Published As

Publication number Publication date
TW200701983A (en) 2007-01-16
NO20065829L (en) 2007-01-25
KR20070010168A (en) 2007-01-22

Similar Documents

Publication Publication Date Title
ZA200801253B (en) Novel use of peptide compounds for treating muscle pain
IL246171A0 (en) Peptide-based compounds
TWI372152B (en) Novel peptide compounds
EP1756092A4 (en) Novel inhibitors of rho-kinases
EP1789086A4 (en) Extended treatment of multiple sclerosis
IL178473A0 (en) Tri(cyclo) substituted amide compounds
IL188430A0 (en) Treatment of tumors
GB0505720D0 (en) Use of uv filters for preventing tanning
GB0505975D0 (en) Novel use of peptide
IL179129A0 (en) Kit for treatment of cancer
IL181185A0 (en) Novel polymorphs of azabicyclohexane
EP1993581A4 (en) Novel use of ubiquitin c-terminal hydrolase-l1
PL1855674T3 (en) Composition for inhibition of cathepsin k
EP1745070A4 (en) Peptide stabilization
IL179072A0 (en) Novel use of peptide compounds for treating dyskinesia
GB0408521D0 (en) Treatment of sepsis
HU0500947D0 (en) Composition for treatment of paradontosis
ZA200708109B (en) Method of peptide synthesis
HUP0500948A2 (en) Composition for treatment of diabeticus paradontosis
IL179528A0 (en) Novel use of peptide compounds for treating amyotrophic lateral sclerosis
EP1874283A4 (en) Use of novel compounds for ibd treatment
GB0405190D0 (en) Purification of peptides
IL189077A0 (en) Novel use of peptide compounds for treating muscle pain
GB0307824D0 (en) Treatment of dyskinesia
GB0615881D0 (en) Novel peptide for treatment of asthma